Astrana Health Inc (ASTH)
37.46
+0.39
(+1.05%)
USD |
NASDAQ |
May 03, 16:00
37.48
+0.02
(+0.05%)
After-Hours: 20:00
Astrana Health Revenue (Quarterly): 353.04M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 353.04M |
| September 30, 2023 | 348.17M |
| June 30, 2023 | 348.21M |
| March 31, 2023 | 337.24M |
| December 31, 2022 | 294.21M |
| September 30, 2022 | 317.00M |
| June 30, 2022 | 269.70M |
| March 31, 2022 | 263.26M |
| December 31, 2021 | 195.10M |
| September 30, 2021 | 227.12M |
| June 30, 2021 | 175.64M |
| March 31, 2021 | 176.06M |
| December 31, 2020 | -140.15M |
| September 30, 2020 | 180.12M |
| June 30, 2020 | 165.17M |
| March 31, 2020 | 165.10M |
| December 31, 2019 | 178.75M |
| September 30, 2019 | 156.06M |
| June 30, 2019 | 130.05M |
| March 31, 2019 | 95.76M |
| December 31, 2018 | 105.46M |
| September 30, 2018 | 167.28M |
| June 30, 2018 | 123.00M |
| March 31, 2018 | 124.17M |
| September 30, 2017 | 40.48M |
| Date | Value |
|---|---|
| June 30, 2017 | 41.58M |
| March 31, 2017 | 14.76M |
| December 31, 2016 | 15.67M |
| September 30, 2016 | 14.62M |
| June 30, 2016 | 12.37M |
| March 31, 2016 | 11.82M |
| December 31, 2015 | 10.66M |
| September 30, 2015 | 11.37M |
| June 30, 2015 | 10.20M |
| March 31, 2015 | 9.588M |
| December 31, 2014 | 7.642M |
| September 30, 2014 | 11.67M |
| June 30, 2014 | 4.094M |
| January 31, 2014 | 2.840M |
| October 31, 2013 | 2.605M |
| July 31, 2013 | 2.593M |
| April 30, 2013 | 2.447M |
| January 31, 2013 | 2.530M |
| October 31, 2012 | 1.965M |
| July 31, 2012 | 1.650M |
| April 30, 2012 | 1.632M |
| January 31, 2012 | 1.545M |
| October 31, 2011 | 1.432M |
| July 31, 2011 | 1.094M |
| April 30, 2011 | 1.040M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-140.15M
Minimum
Dec 2020
353.04M
Maximum
Dec 2023
217.89M
Average
195.10M
Median
Dec 2021
Revenue (Quarterly) Benchmarks
| American Shared Hospital Services | 5.698M |
| Novo Integrated Sciences Inc | 3.171M |
| Cryo-Cell International Inc | 7.852M |
| P3 Health Partners Inc | 346.86M |
| Biote Corp | 45.70M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 12.36M |
| Total Expenses (Quarterly) | 356.91M |
| EPS Diluted (Quarterly) | 0.26 |
| Enterprise Value | 1.458B |
| Gross Profit Margin (Quarterly) | 11.04% |
| Profit Margin (Quarterly) | 3.50% |
| Earnings Yield | 3.44% |
| Operating Earnings Yield | 4.81% |
| Normalized Earnings Yield | 3.595 |